Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

作者: Michele L Taffaro , Bruce E Johnson , Ravi Salgia , Pasi A Jänne

DOI:

关键词: Growth factor receptorPathologyBiologyCancer researchEpidermal growth factorEpidermal growth factor receptorTGF alphaCell growthAutocrine signallingCell cycleGefitinib

摘要: Malignant pleural mesothelioma (MPM) is a rare malignancy with no known curative modality. Approximately 70% of MPMs have high levels expression the epidermal growth factor receptor (EGFR), and subset cell lines derived from MPM patients express both EGFR transforming alpha, suggesting an autocrine role for in MPM. We determined effects inhibition vitro, using four previously untreated epithelial (H2461 H2591), sarcomatoid (H2373), biphasic (MSTO-211H) All expressed at comparable non-small lung carcinoma (NSCLC) line A549, as shown by Western blot analysis. ZD1839 significantly inhibited factor-dependent signaling including phosphorylation AKT extracellular signal-regulated kinases 1 2 all lines. Furthermore, treatment led to significant dose-dependent reduction colony formation (41-89% 10 microM) when cells were grown soft agarose. MSTO-211H, H2461, H2373 more sensitive growth-inhibitory than was NSCLC whereas H2591 had similar sensitivity A549. This variability not related amount present on or degree ZD1839. show that cells, which 89% microM ZD1839, undergo arrest G(1)-S phase cycle corresponding increase p27 levels. However, lines, 41% changes Our findings demonstrate effective against it A549 suggest may be therapeutic option

参考文章(46)
Tony DeBlasio, Mark Rubin, Zhen Fan, Andrew Koff, Tim Soos, John Mendelsohn, Xipu Wu, Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene. ,vol. 12, pp. 1397- 1403 ,(1996)
Valerie W. Rusch, Steven Piantadosi, E. Carmack Holmes, The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 102, pp. 1- 9 ,(1991) , 10.1016/S0022-5223(19)36577-8
Thomas R. Tritton, Brooke T. Mossman, Christine L. Zanella, James Posada, Asbestos Causes Stimulation of the Extracellular Signal-regulated Kinase 1 Mitogen-activated Protein Kinase Cascade after Phosphorylation of the Epidermal Growth Factor Receptor Cancer Research. ,vol. 56, pp. 5334- 5338 ,(1996)
Tony DeBlasio, Zhen Fan, Yang Lu, Ding Peng, John Mendelsohn, Howard Scher, Howard Scher, Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Research. ,vol. 56, pp. 3666- 3669 ,(1996)
Mark G. Kris, Howard I. Scher, Vincent A. Miller, Maureen F. Zakowski, Francis M. Sirotnak, Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase Clinical Cancer Research. ,vol. 6, pp. 4885- 4892 ,(2000)
G Gasparini, W J Gullick, P Bevilacqua, J R Sainsbury, S Meli, P Boracchi, A Testolin, G La Malfa, F Pozza, Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. Journal of Clinical Oncology. ,vol. 10, pp. 686- 695 ,(1992) , 10.1200/JCO.1992.10.5.686
Jeremy P. C. Steele, Jonathan Shamash, Marie T. Evans, Nicole H. Gower, Marc D. Tischkowitz, Robin M. Rudd, Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma Journal of Clinical Oncology. ,vol. 18, pp. 3912- 3917 ,(2000) , 10.1200/JCO.2000.18.23.3912
Patrice C. Ferriola, Jeffrey Everitt, James Mangum, Edilberto Bermudez, Cheryl Walker, Wendy Stewart, Autocrine Growth Stimulation by Transforming Growth Factor α in Asbestos-transformed Rat Mesothelial Cells Cancer Research. ,vol. 55, pp. 530- 536 ,(1995)
Harvey I. Pass, Karen Kranda, Barbara K. Temeck, Irwin Feuerstein, Seth M. Steinberg, Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Annals of Surgical Oncology. ,vol. 4, pp. 215- 222 ,(1997) , 10.1007/BF02306613